Related Experiment Videos
Progress in phototherapy
M C de Araújo1, F A Vaz, J L Ramos
1University of São Paulo Medical School, Brazil.
Insights
Phototherapy is an advanced treatment for newborn jaundice, requiring specific light intensity (6-12 nm). Its use in healthy infants is debated, necessitating careful application until benefits and risks are clear.
Area of Science:
- Neonatal Medicine
- Photobiology
- Pediatrics
Background:
- Neonatal jaundice is common.
- Phototherapy is a standard treatment.
- Concerns exist regarding its routine use in healthy term infants.
Purpose of the Study:
- To present advances in phototherapy for neonatal jaundice.
- To highlight the importance of light intensity for efficacy.
- To address the ongoing debate on phototherapy's utility in healthy newborns.
Main Methods:
- Review of recent phototherapy advancements.
- Discussion of optimal light dosage (6-12 nm).
- Analysis of current clinical practice and evidence.
Main Results:
- Phototherapy efficacy is dose-dependent.
- Specific light wavelengths (6-12 nm) are crucial.
- Evidence for routine use in healthy term infants is inconclusive.
Conclusions:
- Emphasize appropriate phototherapy use.
- Further research is needed to establish consensus on benefits and risks.
- Clinical decisions should weigh evidence carefully.
Abstract:
The purpose of this article is to present a recent advance in phototherapy employed on newborn babies with jaundice. The efficacy of this treatment depends on the intensity of emitted light; it is believed that a dose between 6-12 nm is necessary. The usefulness of phototherapy in healthy, full-term infants is currently being questioned. Therefore, the adequate use of this therapy should be emphasized until a consensus is reached on its advantages and disadvantages.